Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diaryl Ketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115925527A details a Ru-catalyzed hydroarylation for alpha-diarylmethyl ketones, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118580142A reveals a low-palladium carbonylation method for diaryl ketones, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN115028505B reveals a metal-free method for synthesizing high-purity fluorinated ketones. Discover cost reduction in fine chemical manufacturing and scalable routes.
Patent CN112300061B details a novel Ru-catalyzed C-H acylation method using amides, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates.
Patent CN106146271B reveals a palladium-catalyzed route for diaryl ketones offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115477575B details a transition-metal-free synthesis for diaryl ketones. This method offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Novel nickel-catalyzed method for diaryl ketones. High purity, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN103242223A details a Pd-catalyzed decarboxylative coupling for 2-pyridyloxydiaryl ketones, offering cost reduction in API manufacturing and scalable production.
Patent CN110483223B reveals a high-efficiency pyridine-palladium catalyzed method for diaryl ketones, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106478387A details palladium-catalyzed synthesis offering high yields and mild conditions for scalable pharmaceutical intermediate manufacturing and supply chain stability.
Efficient Pd-catalyzed synthesis of 2-pyridinecarboxamide diaryl ketones. High purity pharma intermediates with scalable routes for cost-effective manufacturing.
Patent CN115925527B details a Ru-catalyzed method for high-purity API intermediate synthesis, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN102603624A reveals a scalable Pd-catalyzed route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN103242223A details a green Pd-catalyzed oxidative decarboxylative coupling for 2-pyridyloxydiaryl ketones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103242223B enables eco-friendly synthesis of high-purity API intermediates with simplified purification and reduced lead times for pharmaceutical supply chains.